Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1–infected children
Year: 2007
Type: article
Institutions: University of Colorado Health, University of Colorado Denver, University of California, Los Angeles, Harvard University, National Institutes of Health, University of Southern California, Children's Hospital Los Angeles, Children's National, University of Medicine and Dentistry of New Jersey, National Institute of Allergy and Infectious Diseases, Frontier Science & Technology Research Foundation, Inc., Social and Scientific Systems (United States), Baylor College of Medicine
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS, G1134135803, Baylor-UT Houston Center for AIDS Research, G18691040, HIV-1 Therapy with CCR5 mAB PRO 140-Overview, Pediatric Clinical Trials Program for AIDS, G2129911619, G2132012078, G2705502615, G3126028604, G3258243794, G3341501247, G3381016547, G348093950, Los Angeles Pediatric AIDS Clinical Trials Unit, General Clinical Research Center, WOMEN AND INFANTS TRANSMISSION STUDY (WITSIV), G444342022, G4561803324, General Clinical Research Center, General Clinical Research Center, General Clinical Research Center, G5162579792, General Clinical Research Center, General Clinical Research Center, General Clinical Research Center, SIGNALING &METABOLIC ROLES OF GLUCOSE IN SPERM, G6830587703, G686464379, TRANSGENIC PRODUCTION OF CD4-IGG2 FOR HIV THERAPY, General Clinical Research Center, Transgenic Production of CD4-IgG2 for HIV Therapy, Statistical/Data Management Center-Pediatric AIDS CTG, G760152555, Philadelphia Pediatric AIDS Clinical Trials Unit, G868895564, Pediatric ACTG Coordinating and Operations Center, GENERAL CLINICAL RESEARCH CENTER, G908435047
OpenAlex ID: W2124569623